Trial · NCT05283304
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Methamphetamine-negative Urine Samples | Injectable Buprenorphine (BUP-inj) | 0 | urine samples | ||
| Number of Methamphetamine-negative Urine Samples | Injectable Placebo (PBO-inj) | 0 | urine samples | ||
| Treatment Effective Score (TES) for MA-negative UDS Results | Injectable Buprenorphine (BUP-inj) | 0 | Inter-Quartile Range 0 to 0 | score on a scale | |
| Treatment Effective Score (TES) for MA-negative UDS Results | Injectable Placebo (PBO-inj) | 0 | Inter-Quartile Range 0 to 0 | score on a scale | |
| Number of Days of Methamphetamine Use During the Medication Phase | Injectable Buprenorphine (BUP-inj) | 56.0 | Standard Deviation 25.46 | days | |
| Number of Days of Methamphetamine Use During the Medication Phase | Injectable Placebo (PBO-inj) | 53.8 | Standard Deviation 27.54 | days | |
| Treatment Effective Score (TES) for Opioid Negative UDS Results | Injectable Buprenorphine (BUP-inj) | 0.62 | Inter-Quartile Range 0.5 to 0.75 | score on a scale | |
| Treatment Effective Score (TES) for Opioid Negative UDS Results | Injectable Placebo (PBO-inj) | 0.75 | Inter-Quartile Range 0.48 to 0.9 | score on a scale | |
| Number of Days of Opioid Use During the Medication Phase | Injectable Buprenorphine (BUP-inj) | 0 | Standard Deviation 0 | days | |
| Number of Days of Opioid Use During the Medication Phase | Injectable Placebo (PBO-inj) | 0 | Standard Deviation 0 | days | |
| Treatment Effective Score (TES) for MA and Opioid Co-Use Compiled | Injectable Buprenorphine (BUP-inj) | 0 | Inter-Quartile Range 0 to 0 | score on a scale | |
| Treatment Effective Score (TES) for MA and Opioid Co-Use Compiled | Injectable Placebo (PBO-inj) | 0 | Inter-Quartile Range 0 to 0 | score on a scale | |
| Number of Days of MA and Opioid Co-use During the Medication Phase | Injectable Buprenorphine (BUP-inj) | 0 | Standard Deviation 0 | days | |
| Number of Days of MA and Opioid Co-use During the Medication Phase | Injectable Placebo (PBO-inj) | 0 | Standard Deviation 0 | days |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05283304/results